. 2015 Nov 6;9:2073–2080. doi: 10.2147/OPTH.S90628

Table 3.

Comparison of postsurgical results between patients assigned to the BSS plus^® or Z-Celcoat™ group

	BSS plus^® group	Z-Celcoat™ group	P-value
BCVA
Baseline	0.42±0.17	0.44±0.18	0.448
Week 1	0.77±0.17	0.73±0.15	0.010^a
Week 6	0.83±0.17	0.83±0.14	0.663
ΔBCVA (P-value)
Baseline/week 1	0.36±0.18 (<0.001)^a	0.29±0.22 (<0.001)^a	0.009^a
Baseline/week 6	0.41±0.18 (<0.001)^a	0.39±0.21 (<0.001)^a	0.398
IOP (mmHg)
Baseline	15.5±2.8	15.9±2.5	0.206
Day 1	15.2±2.5	16.4±2.1	<0.001^a
Week 1	15.0±2.2	15.9±2.0	0.001^a
Week 6	15.0±2.1	15.9±1.8	0.001^a
ΔIOP (mmHg) (P-value)
Baseline/day 1	−0.3±3.3 (0.331)	0.49±2.9 (0.117)	0.107
Baseline/week 1	−0.5±3.0 (0.077)	0.0±2.6 (0.832)	0.119
Baseline/week 6	−0.5±3.0 (0.116)	0.0±2.7 (0.971)	0.217
ECD (cells/mm²)
Baseline	2,506±310	2,433±261	0.107
Week 1	2,348±347	2,298±354	0.407
Week 6	2,314±381	2,272±340	0.361
ΔECD (cells/mm²)/(%) (P-value)
Baseline/week 1	−159±294/(6.3) (<0.001)^a	−134±257/(5.5) (<0.001)^a	0.391
Baseline/week 6	−192±300/(7.7) (<0.001)^a	−160±252/(6.6) (<0.001)^a	0.571
ECS (µm²)
Baseline	406±57	416±50	0.09
Week 1	437±81	447±83	0.409
Week 6	446±91	452±83	0.363
ΔECS (µm²)/(%) (P-value)
Baseline/week 1	32±67/(7.6) (<0.001)^a	31±60/(7.5) (<0.001)^a	0.645
Baseline/week 6	41±74/(9.9) (<0.001)^a	35±64/(8.7) (<0.001)^a	0.779

Notes: Results and changes within each group are displayed in correspondent columns and comparisons between both groups are arranged in correspondent lines.

Significant differences. Data are represented as mean ± standard deviation.

Abbreviations: BSS, balanced salt solution; BCVA, best-corrected visual acuity; IOP, intraocular pressure; ECD, endothelium cell density; ECS, endothelium cell size.